LGM
TIL icon

Logos Global Management’s Instil Bio TIL Stock Holding History

Logos Global Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,594
Closed -$1.61M – 48
2022
Q3 		$1.61M Sell
16,594
-1,896
-10% -$217K 0.2% 33
2022
Q2 		$1.71M Sell
18,490
-365
-2% -$51.7K 0.31% 23
2022
Q1 		$4.05M Buy
+18,855
New +$4.41M 0.53% 28
2021
Q4 		– Sell
-63,855
Closed -$22.8M – 78
2021
Q3 		$22.8M Sell
63,855
-20,988
-25% -$7.83M 1.65% 20
2021
Q2 		$32.8M Sell
84,843
-7,500
-8% -$2.78M 2.76% 9
2021
Q1 		$46.3M Buy
+92,343
New +$47.4M 4.52% 5

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Logos Global Management's TIL Position: Q4 2022 in Review

Logos Global Management sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 16,594 shares — an estimated $1.61M sold.

Logos Global Management first reported a position in TIL in Q1 2021 and held it in 6 quarters. The position peaked at $46.3M in Q1 2021. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

  • Logos Global Management reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
  • Logos Global Management sold 16,594 Instil Bio shares in Q4 2022, an estimated $1.61M.
  • Logos Global Management first reported a position in Instil Bio in Q1 2021 and held it in 6 quarters.
  • Logos Global Management's Instil Bio position peaked at $46.3M in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on Logos Global Management's 13F filing for Q4 2022, filed 14 Feb 2023.